12.27USD+3.41%Mkt Cap: 827.16M USDP/E: —Last update: 2026-05-26
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical ch…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap827.16M USD
Enterprise Value3.58B USD
Revenue (TTM)2.66B USD
Gross Profit1.27B USD
Net Income (TTM)-1.13B USD
Revenue/Share39.09 USD
Last Price12.27 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2197981051
Valuation
P/E (Trailing)—
P/E (Forward)5.08
PEG2.06
EV/EBITDA7.28
EV/Revenue1.35
P/S0.32
P/B0.46
EPS (TTM)-17.85
EPS (Forward)2.44
52W Range
9.9209% of range35.58
52W High35.58 USD
52W Low9.920 USD
Profitability
Gross Margin46.67%
Oper. Margin-4.10%
EBITDA Margin18.50%
Profit Margin-41.45%
ROE-58.93%
ROA-19.62%
Growth
Revenue Growth-10.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF105.20M USD
CapEx (TTM)188.20M USD
FCF Margin7.85%
FCF Yield25.22%
Net Debt2.73B USD
Net Debt/EBITDA5.56
Balance Sheet
Debt/Equity1.48
Current Ratio1.43
Quick Ratio0.65
Book Value/Sh27.19 USD
Cash/Share2.059 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)18.63 USD
Target Range11.00 USD – 38.00 USD
# Analysts4
Ownership
Shares Out.68.19M
Float62.20M
Insiders0.83%
Institutions121.79%
Short Interest
Short Ratio4.7d
Short % Float25.67%
Short % Out.18.79%
Shares Short12.81M
Short (prev mo.)12.79M
Technical
SMA 5013.86 (-11.5%)
SMA 20023.81 (-48.5%)
Beta0.74
S&P 52W Chg28.31%
Avg Vol (30d)2.77M
Avg Vol (10d)2.29M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—